Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Development deals
Biotech
Boehringer Ingelheim to surf with Melbourne biotech
Boehringer Ingelheim is heading into the surf with Kinoxis Therapeutics in a $181 million biobucks deal to develop neuropsychiatric disorder drugs.
Annalee Armstrong
May 5, 2023 10:58am
Confo hands baton to Lilly for non-opioid pain med in $40M deal
Mar 2, 2023 5:00am
Destiny seals C. diff therapy's phase 3 fate with Sebela
Feb 24, 2023 10:10am
Sanofi makes $75M preclinical bet to join busy Parkinson's field
Jan 12, 2022 8:45am
Amgen teams up with Arrakis in $75M RNA-destroying research deal
Jan 11, 2022 9:00am
Pfizer locks in 2 partners to solidify status as mRNA powerhouse
Jan 10, 2022 6:50am